Study Summary
This trial will see if blue-light therapy can improve symptoms in patients with psoriasis or Grover's Disease.
Eligible Conditions
- Grover's Disease
- Plaque Psoriasis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 1 Secondary · Reporting Duration: Time Frame: 1 year
Time Frame: 1 year
Assess user experience
Cellular analysis of Blue light phototherapy
Efficacy of blue light therapy for patients with Grover's disease or psoriasis vulgaris
Efficacy of blue light therapy for patients with psoriasis vulgaris
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Adult treatment arm
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Blue light phototherapy · No Placebo Group · N/A
Adult treatment arm
Device
Experimental Group · 1 Intervention: Blue light phototherapy · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: time frame: 1 year
Who is running the clinical trial?
T-Cellerate LLCUNKNOWN
Northwestern UniversityLead Sponsor
1,458 Previous Clinical Trials
790,065 Total Patients Enrolled
Shuai XuPrincipal InvestigatorNorthwestern University
6 Previous Clinical Trials
325 Total Patients Enrolled
Eligibility Criteria
Age 18 - 89 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments